Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients

Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C

(2016) C. Sagnelli et al.   CLINICAL MICROBIOLOGY AND INFECTION

CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection

(2016) Nicola Coppola et al.   DIGESTIVE AND LIVER DISEASE

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype

(2016) Caterina Sagnelli et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The endocannabinoid system and its therapeutic implications in rheumatoid arthritis

(2015) Huan Gui et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Role of genetic polymorphisms in hepatitis C virus chronic infection

(2015) Nicola Coppola   World Journal of Clinical Cases

Review article: the endocannabinoid system in liver disease, a potential therapeutic target

(2014) P. P. Basu et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins

(2014) Erinn S. Raborn et al.   LIFE SCIENCES

Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C

(2014) Nicola Coppola et al.   PLoS One

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients

(2013) Caterina Sagnelli et al.   Brazilian Journal of Infectious Diseases

Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C

(2013) Nicola Coppola et al.   Clinical Gastroenterology and Hepatology

Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection

(2013) C. Sagnelli et al.   INFECTION

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

(2013) Slava Rom et al.   Journal of Neuroimmune Pharmacology

The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention

(2012) Francesca Rossi et al.   PHARMACOLOGICAL RESEARCH

Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells

(2012) Cristina Maria Costantino et al.   PLoS One

CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura

(2011) F. Rossi et al.   HAEMATOLOGICA

Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties

(2011) Francesca Rossi et al.   HEPATOLOGY

Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice

(2011) Alexandre Louvet et al.   HEPATOLOGY

Comorbidity-Related Treatment Outcomes among HIV-Infected Adults in the Bronx, NY

(2011) Carolyn Chu et al.   JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE

Liver Histology in HIV/Hepatitis C-Coinfected and HCV-Monoinfected Patients With Persistently Normal Alanine Aminotransferases

(2010) Caterina Sagnelli et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor

(2010) Alex Carrasquer et al.   Pharmacogenetics and Genomics

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors

(2010) Maria Teresa Cencioni et al.   PLoS One

Hepatitis C Prevalence Among HIV-Positive MSM in San Francisco: 2004 and 2008

(2010) H. Fisher Raymond et al.   SEXUALLY TRANSMITTED DISEASES

Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS)

(2009) Toni Frederick et al.   AIDS PATIENT CARE AND STDS

Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection

(2009) E. Angeli et al.   CURRENT HIV RESEARCH

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T Cells

(2009) Dongyang Yu et al.   PLoS Pathogens

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

(2008) Hla-Hla Thein et al.   AIDS

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

(2008) Fabrizio Montecucco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Influence of Cannabis Use on Severity of Hepatitis C Disease

(2008) Julie H. Ishida et al.   Clinical Gastroenterology and Hepatology

HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCV

(2008) Evangelista Sagnelli et al.   HEPATOLOGY

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease

(2008) G. Cabral et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

CB2receptor-mediated migration of immune cells: it can go either way

(2007) A M Miller et al.   BRITISH JOURNAL OF PHARMACOLOGY